| Use of Palivizumab in Germany: Data from 2002-2007. | |
| | |
MedLine Citation:
|
PMID: 21509705 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: The German Palivizumab Registry refers to a post-marketing observational study of palivizumab administration during 5 consecutive respiratory syncytial virus (RSV) seasons (2002/2003 -2006/2007). PATIENTS AND METHODS: The registry provided data on drug administration, risk factors for complicated RSV disease, rehospitalisation rates for infants receiving RSV prophylaxis, and parental adherence. 49 608 administrations were documented in 10 686 patients (average of 4.6 per patient). RESULTS: 35% of infants received >5 monthly injections. Median gestational age at birth was 29 weeks (range 23-41 weeks), median birth weight was 1 350 g (range 320-6 620 g), 3% were attending day care, 46% lived in a household with children <12 years, 18% were exposed to tobacco smoke at home, 10% had a family history of asthma, and 31% had congenital heart disease. The risk of serious adverse events possibly or probably related to palivizumab administration was 0.2 per 1 000 administrations. According to a worst-case calculation, the rehospitalisation rate related to RSV infection was 2.5% in children who received prophylaxis. CONCLUSION: The German Palivizumab Registry provides a comprehensive dataset describing the use of palivizumab in Germany from 2002 to 2007, and areas for improvement identified in this registry can be applied to enhance the use of palivizumab in the future. |
| | |
Authors:
|
A Simon; H Nowak; R Sterz |
Related Documents
:
|
6574525 - Plasma prostaglandin e2 and f2 alpha in preterm infants: association with respiratory d... 2320395 - Stroke volume and left ventricular output in preterm infants with patent ductus arterio... 2374215 - The effect of back closure on detrusor function in neonates with myelomeningocele. 8267455 - Thoracoscopic clipping of patent ductus arteriosus in premature infants. 11261425 - Impact of prenatal screening on the birth status of fetuses with down syndrome at an ur... 10685195 - Serum cortisol levels in very low birth weight infants of substance-abusing mothers. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-20 |
Journal Detail:
|
Title: Klinische Padiatrie Volume: - ISSN: 1439-3824 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0326144 Medline TA: Klin Padiatr Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© Georg Thieme Verlag KG Stuttgart · New York. |
Affiliation:
|
Children's Hospital Medical Center, Pediatric Hematology and Oncology, Homburg, Germany. |
Vernacular Title:
|
Anwendung von Palivizumab in Deutschland - Daten von 2002-2007. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mycoplasma pneumoniae-Associated Encephalitis in Childhood - Nervous System Disorder During or After...
Next Document: Update on Relapses in Unilateral Nephroblastoma Registered in 3 Consecutive SIOP/GPOH Studies - A Re...